Cellectar Biosciences INC NEW (CLRB) is a publicly traded Healthcare sector company. As of July 11, 2026, CLRB trades at $2.74 with a market cap of $22.14M and a P/E ratio of -0.33. CLRB moved +1.08% today. Year to date, CLRB is -4.41%; over the trailing twelve months it is -42.80%. Its 52-week range spans $2.20 to $58.50. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces CLRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CLRB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.74 |
| Market Cap | $22.14M |
| P/E Ratio | -0.33 |
| EPS | $-8.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $58.50 |
| 52-Week Low | $2.20 |
| Volume | 65.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-21.79M |
| Gross Margin | 0.00% |
3 analysts cover CLRB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.33.